Allianz Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Buy |
|
|||||
|
2025
Q1 | $3.98M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $806K | Buy |
|
|||||
|
2024
Q1 | $1M | Sell |
|
|||||
|
2023
Q4 | $1.34M | Sell |
|
|||||
|
2023
Q3 | $1.97M | Sell |
|
|||||
|
2023
Q2 | $4.55M | Sell |
|
|||||
|
2023
Q1 | $12.1M | Sell |
|
|||||
|
2022
Q4 | $37.9M | Buy |
|
|||||
|
2022
Q3 | $28.4M | Sell |
|
|||||
|
2022
Q2 | $36.2M | Buy |
|
|||||
|
2022
Q1 | $36.7M | Buy |
|
|||||
|
2021
Q4 | $43.9M | Buy |
|
|||||
|
2021
Q3 | $27.8M | Buy |
|
|||||
|
2021
Q2 | $22.4M | Sell |
|
|||||
|
2021
Q1 | $21M | Buy |
|
|||||
|
2020
Q4 | $15.7M | Sell |
|
|||||
|
2020
Q3 | $14M | Sell |
|
|||||
|
2020
Q2 | $18M | Sell |
|
|||||
|
2020
Q1 | $23M | Sell |
|
|||||
|
2019
Q4 | $32.4M | Buy |
|
|||||
|
2019
Q3 | $27.3M | Buy |
|
|||||
|
2019
Q2 | $14.1M | Sell |
|
|||||
|
2019
Q1 | $14.8M | Sell |
|
|||||
|
2018
Q4 | $14.4M | Sell |
|
|||||
|
2018
Q3 | $20.1M | Buy |
|
|||||
|
2018
Q2 | $18.6M | Buy |
|
|||||
|
2018
Q1 | $16.1M | Sell |
|
|||||
|
2017
Q4 | $15.8M | Sell |
|
|||||
|
2017
Q3 | $16.3M | Buy |
|
|||||
|
2017
Q2 | $11.5M | Buy |
|
|||||
|
2017
Q1 | $401K | Buy |
|
|||||
|
2016
Q4 | $203K | Sell |
|
|||||
|
2016
Q3 | $863K | Buy |
|
|||||
|
2016
Q2 | $326K | Sell |
|
|||||
|
2016
Q1 | $334K | Sell |
|
|||||
|
2015
Q4 | $699K | Sell |
|
|||||
|
2015
Q3 | $717K | Sell |
|
|||||
|
2015
Q2 | $1.03M | Buy |
|
|||||
|
2015
Q1 | $217K | Buy |
|